Showing 251-260 of 2784 results for "".
AAFPRS Mission Trip to Ukraine
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/aafprs-mission-trip-to-ukraine/33931/Founded in 1992, FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery. Both in the United States and abroad, AAFPRS surgeons and other medical professionaMATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: RealSelf's Beyond Beauty; AAFPRS Stats; More
https://modernaesthetics.com/series/matv-news/matv-news-realselfs-beyond-beauty-aafprs-stats-more/33525/RealSelf’s new series, Beyond Beauty, explores humanitarian work of plastic surgeons; results of the latest survey by the American Academy of Facial Plastic and Reconstructive Surgery show social media, selfies, and prejuvenation trends are driving growth in surgical and non-surgical procedures; andMATV News: Obagi Sold; AAFPRS Meeting Coverage; FDA Warning on Illegal Injectable Silicone
https://modernaesthetics.com/series/matv-news/matv-news-obagi-sold-aafprs-meeting-coverage-fda-warning-on-illegal-injectable-silicone/33296/Valeant completes sale of Obagi Medical, coverage of the American Academy of Facial Plastic and Reconstructive Surgery's Annual Meeting, and long-term results of BTL Vanquish are promising. Plus, coverage of the FDA's warning about the illegal use of injectable silicone for body contouring. And howMATV News: The Art of Injecting; Chemicals in Beauty Products; Neurotoxin Pipeline
https://modernaesthetics.com/series/matv-news/matv-news-the-art-of-injecting-chemicals-in-beauty-products-neruotoxin-pipeline/33322/A highly detailed body painting project is helping physicians better improve botulinum toxin injection techniques, a new study shows women with skin of color have higher levels of beauty-product related chemicals in their bodies, and a neuromodulator in the pipeline is showing promise. And, a look aMATV News: Valeant Sells Obagi; Aesthetic Trends Around the Globe
https://modernaesthetics.com/series/matv-news/matv-news-valeant-sells-obagi-aesthetic-trends-around-the-globe/33323/Valeant agrees to sell its Obagi Medical Products business, Syneron Candela is now a private company, and Allergan acquired the Reginica Advanced Rejuvenation System line. Also, coverage of the latest trends in aesthetics, according to new statistics from the International Society of Aesthetic PlastMATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aMATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus VelocityDealing With the Unhappy Patient
https://modernaesthetics.com/conferences/tell-all-tribune/dealing-with-the-unhappy-patient/33791/Dealing With the Unhappy Patient